September 23, 2026

Female patients less likely to receive invasive care

Review identifies recurring sex-based differences across specialties, including lower use of intensive and guideline-compliant treatment among female patients.

MDSpire News

September 21, 2026

Mapping epilepsy in Down syndrome

Seven international cohorts examined epilepsy incidence, cognitive trajectories, and survival in adults with Down syndrome.

MDSpire News

September 16, 2026

Intranasal EVs may slow Alzheimer's disease

Amniotic cell–derived extracellular vesicles improved cognition while reducing amyloid-beta accumulation and neuroinflammation in experimental models.

MDSpire News

September 11, 2026

Can external counterpulsation help early Alzheimer disease?

Researchers compared full‐pressure and low‐pressure external counterpulsation during a 12‐month trial in patients with clinically diagnosed early Alzheimer disease.

MDSpire News

September 08, 2026

Cognitive decline emerges as next front in 9/11 care

As the WTC Health Program population passes age 60, clinicians are tracking a rise in impairment that doesn't match the usual pattern of Alzheimer's disease.

MDSpire News

September 02, 2026

Medical Oddities: Dogs share our mortality markers

The bond with dogs runs deeper, the brain enjoys a good sweat, love on screen gets real, and tea carries a little more weight.

MDSpire News

August 27, 2026

Medical Oddities: Could multilingualism keep you young?

From multilingual minds to pomegranate hearts, gastric mischief, and swishable tea, science stays delightfully odd.

MDSpire News

August 24, 2026

FDA clears pTau217 blood test for Alzheimer's disease

The assay uses the same validated clinical cutoffs across primary and specialty care settings.

MDSpire News

August 19, 2026

Who develops dementia after 90?

Investigators examined associations between demographic and genetic factors and dementia risk while accounting for the competing risk of mortality.

MDSpire News

August 14, 2026

FDA approves tau PET imaging agent

The F18-labeled agent is indicated for brain PET imaging to identify tau neurofibrillary tangle pathology.

MDSpire News